Phase
Condition
Depression
Pancreatic Cancer
Digestive System Neoplasms
Treatment
N/AClinical Study ID
Ages > 40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
40 years of age or older at the time of recruitment.
Unresectable/inoperable pancreatic adenocarcinoma (stage III or IV), receivingGemcitabine or Gemcitabine-based combination therapy.
If in the "depressed" sample, patients with pancreatic cancer must meet DSM-IVcriteria for a major depressive syndrome (based on the SCID) AND have an HDRS score of 18 or greater.
If in the "non-depressed" sample, patients with pancreatic cancer must not meet DSM-IVcriteria for a major depressive syndrome (based on the SCID) AND must have a HDRSscore of 17 or less.
Exclusion
Exclusion Criteria:
- A. Patient has reported experiencing or medical record indicates a serious medical event (i.e.,medical hospitalization (excluding hospitalization related to cancerdiagnosis/treatment),myocardial infarction, stroke) within the year preceding studyparticipation. B. Patient has reported the presence of or medical record indicates:
Type 1 Diabetes, unrelated to cancer diagnosis
renal failure requiring dialysis
inflammatory bowel disease 3. Patient has reported the presence of or medical recordindicates an active secondary cancer diagnosis, however patients who have been treatedfor a past cancer and are 2 years disease free from that cancer can participate.
- Presence of a medical/surgical condition obtained through self-report associatedwith elevated cytokine levels, such as:
HIV/AIDS
Auto-immune diseases such as SLE, Multiple Sclerosis, Rheumatoid Arthritis,Polymyalgia Rheumatica, Temporal Arteritis, Chronic Fatigue Syndrome, severe allergies
Congestive Heart Failure
Recent stroke
Alzheimer's Disease
Active infection;
Acute pancreatitis
Acute pericarditis
Acute hepatitis including Hepatitis C
Recent vaccination for viral disease
Major surgery within the past 6 weeks
- Patient Reports Receiving treatment (within two weeks) with:
Interleukin
Interferon
Thalidomide
NSAID's
Cox-2 inhibitors
Cancer vaccine therapies
Self-reported diagnosis with a major psychiatric disorder other than depression (e.g. psychosis secondary to Bipolar Disorder, Schizophrenia, Schizo-affectiveillness, substance abuse) so severe that, in the opinion of the study staff, wouldinterfere with a patient's ability to give informed consent for research.
Cognitive impairment so severe that, in the opinion of the study staff, wouldinterfere with a patient's ability to give informed consent or complete study measuresfor research.
Study Design
Study Description
Connect with a study center
Memorial Sloan-Kettering Cancer Center
New York, New York 10065
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.